Fed Interest Rate Hikes to Expose Balance Sheet Problems at Many US Banks

Published: May 4, 2023 17:04
The US Federal Open Market Committee (FOMC) continued its streak of rate hikes for more than a year, raising the federal funds rate by 25 basis points to a target range of 5-5.25%.

The US Federal Open Market Committee (FOMC) continued its streak of rate hikes for more than a year, raising the federal funds rate by 25 basis points to a target range of 5-5.25%.

The Fed's move was widely in line with market expectations. It is worth noting that this policy statement did not refer to the language that previously suggested that interest rate hikes would definitely continue.

The statement did note the impact of a "credit crunch" on the economy going forward, and said the FOMC would "take into account the cumulative tightening of monetary policy, the lagged effects of monetary policy on economic activity and inflation, and economic and financial developments." Still, the Fed may be fighting a two-front war, and its rate hikes could expose balance sheet problems at many U.S. banks.

Goldman Sachs, Trafigura See Copper Price Skyrocketing to All-Time High, Citing Stocking Out

Weak Electric Vehicle Pricing Will Spread To New Car Market, Analyst Says

JP Morgan Chase, Citigroup and Deutsche Bank See US Recession in the Cards

Rio Tinto: Pilbara Iron Ore Shipments Hit All-Time High in the First Quarter, Copper Output at 145,000 mt

Goldman Sachs: European Central Bank to Raise Interest Rates Three Times, Ups Forecast for Peak Interest Rate

IEA: Global Electric Vehicle Sales Proliferated in 2022, China Led the Growth


Data Source Statement: Except for publicly available information, all other data are processed by SMM based on publicly available information, market communication, and relying on SMM's internal database model. They are for reference only and do not constitute decision-making recommendations.

For any inquiries or for more information, please contact: lemonzhao@smm.cn
For more information on how to access our research reports, please contact:service.en@smm.cn
Related News
[SMM Precious Metals Express]
Sep 4, 2026 18:12
[SMM Precious Metals Express]
Read More
[SMM Precious Metals Express]
[SMM Precious Metals Express]
Northam Platinum is advancing large-scale renewable energy and energy storage deployment, with a plan to turn its Eland mine into South Africa’s first PGM mine operated entirely on renewable energy. Chief Executive Officer Paul Dunne stated at the annual results briefing on August 28 that Eland not only has the conditions to switch to fully green power, but has also achieved a positive water balance. The company plans to phase out external water sources by the end of this decade, moving the mine toward a truly low-carbon, low-water-dependence "green mine" model.
Sep 4, 2026 18:12
[SMM Precious Metals Express]
Sep 4, 2026 18:05
[SMM Precious Metals Express]
Read More
[SMM Precious Metals Express]
[SMM Precious Metals Express]
In its latest annual results briefing, Northam Platinum unusually identified artificial intelligence, data storage, electronics and robotics as key new sources of future platinum-group metals (PGM) demand, sending a notable signal to the PGM market. Chief Executive Officer Paul Dunne said the company remains bullish on platinum, rhodium, iridium and ruthenium, citing declining supply from South African mines and still-supportive autocatalyst demand, alongside growing new applications in AI and high-tech industries. He noted that the PGM market remains in supply deficit, while industrial demand stays robust driven by emerging applications.
Sep 4, 2026 18:05
[SMM Precious Metals Express]
Sep 4, 2026 17:58
[SMM Precious Metals Express]
Read More
[SMM Precious Metals Express]
[SMM Precious Metals Express]
A research team at Utkal University in India has published a review on organoiridium(III) anticancer complexes, focusing on how Schiff base and oxime ligands affect the biological activity, cytotoxicity and mechanisms of action of Ir(III) complexes. Platinum-based drugs such as cisplatin, carboplatin and oxaliplatin have demonstrated that platinum-group metals (PGMs) can be developed into large-scale clinical therapeutics. However, nephrotoxicity, drug resistance and non-selective damage to healthy cells are driving metal-drug research to extend toward other PGMs including ruthenium (Ru), iridium (Ir) and osmium (Os).
Sep 4, 2026 17:58